A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia

Borthakur, Gautam ; Odenike, Olatoyosi ; Aldoss, Ibrahim ; Rizzieri, David A. ; Prebet, Thomas ; Chen, Chris ; Popovic, Relja ; Modi, Dimple A. ; Joshi, Rujuta H. ; Wolff, Johannes E. ; Jonas, Brian A.

Cancer, 2021-08, Vol.127 (16), p.2943-2953 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível